Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer (Q24795614)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer |
scientific article |
Statements
Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer (English)
0 references
2003
0 references
5
0 references
2
0 references
96-100
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference